Clinical trial
Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of…
NCT00137488 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00137488 |
|---|---|
| Title | Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG) |
| Official title | Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG) |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Glioma |
| Intervention type | Device |
| Interventions | imaging and angiogenic profiles |
| Enrollment | 10 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| First posted | Aug 30, 2005 |
| Last update posted | Feb 26, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: